Infectious Diseases

Medicine & Life Sciences

1. Transplant Recipients 100%
2. HIV 93%
3. Cytomegalovirus 92%
4. Infections 85%
5. Transplants 57%
6. Adenoviridae 55%
7. Cytomegalovirus Infections 52%
8. Liver Transplantation 50%
9. T-Lymphocytes 48%
10. Coronavirus 48%
11. HIV-1 45%
12. Therapeutics 41%
13. Virus Diseases 40%
14. Antiviral Agents 39%
15. HIV Infections 37%
16. Viruses 36%
17. Vaccines 35%
18. Organ Transplantation 33%
19. Endocarditis 32%
20. Equipment and Supplies 32%
21. Apoptosis 30%
22. Hepacivirus 29%
23. Human Herpesvirus 6 27%
24. SARS Virus 27%
25. Opportunistic Infections 26%
26. Serogroup 25%
27. Mortality 24%
28. Transplantation 24%
29. Community-Based Participatory Research 22%
30. Pharmaceutical Preparations 21%
31. Vaccination 21%
32. Tuberculosis 20%
33. Bacteremia 20%
34. Retroviridae Infections 20%
35. Immunization 19%
36. Refugees 19%
37. Kidney 19%
38. Ganciclovir 18%
39. Genes 18%
40. Pandemics 17%
41. Joints 17%
42. Protease Inhibitors 17%
43. Allografts 17%
44. Propionic Acidemia 16%
45. Human Influenza 16%
46. Genetic Therapy 16%
47. Proteins 15%
48. Cell Death 15%
49. Epidemiology 15%
50. Tissue Donors 15%
51. Chronic Hepatitis C 15%
52. DNA 14%
53. Liver 13%
54. Population 13%
55. Lung 13%
56. Immunocompromised Host 13%
57. HIV Protease Inhibitors 13%
58. Viremia 13%
59. Severe Acute Respiratory Syndrome 13%
60. Valganciclovir 12%
61. Confidence Intervals 12%
62. Incidence 12%
63. Adenovirus Vaccines 12%
64. Human Adenoviruses 12%
65. Mycoses 12%
66. Caspase 8 12%
67. In Vitro Techniques 11%
68. Polymerase Chain Reaction 11%
69. Anti-Bacterial Agents 11%
70. Safety 11%
71. Viral Load 11%
72. Herpesviridae Infections 11%
73. Hematopoietic Stem Cells 11%
74. Acquired Immunodeficiency Syndrome 11%
75. Reverse Transcriptase Inhibitors 11%
76. Cryptococcosis 10%
77. Toll-Like Receptor 2 10%
78. AIC246 10%
79. Nelfinavir 10%
80. Human Herpesvirus 7 10%
81. Peptides 10%
82. Hospitalization 10%
83. Highly Active Antiretroviral Therapy 10%
84. Fever 10%
85. Anti-Retroviral Agents 10%
86. Morbidity 10%
87. Feline Immunodeficiency Virus 10%
88. Staphylococcus aureus 10%
89. Kidney Transplantation 10%
90. Invasive Fungal Infections 9%
91. Antigens 9%
92. Ligands 9%
93. Heme Oxygenase-1 9%
94. CD4 Lymphocyte Count 9%
95. Hematopoietic Stem Cell Transplantation 9%
96. Ritonavir 9%
97. Communicable Diseases 9%
98. Polyethylene Glycols 9%
99. Ribavirin 9%
100. Heart 9%